The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI1.L Regulatory News (TI1)

  • There is currently no data for TI1

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Repurchase

2 Dec 2020 07:00

RNS Number : 1964H
Trian Investors 1 Limited
02 December 2020
 

2 December 2020

 

TRIAN INVESTORS 1 LIMITED

(the "Company")

 

Company Share Repurchase

 

 

Announcement of Ferguson Dividend

On 29 September 2020, after taking into account Ferguson plc's ("Ferguson's") prospects and financial position, the Ferguson board of directors announced a final dividend of 208.2 US cents per share, to be paid on 11 December 2020 to all shareholders of record at 13 November 2020. The dividend effectively reinstates the Ferguson interim dividend that was previously withdrawn in April 2020 and is in line with the total dividends paid by Ferguson to its shareholders in 2019. Ferguson stated that dividend payments in 2021 will revert back to the normal one third/two thirds split between an interim and final dividend.

The payment of the dividend is expected to result in Trian Investors 1, L.P. (the "Investment Partnership") receiving approximately $9.8 million (or approximately £7.3 million) in the aggregate.

Company Share Repurchase

In anticipation of the Ferguson dividend payment, the Investment Partnership recently informed the Company's board of directors (the "Board") that it intends to distribute approximately £4 million in excess cash reserves to the Company.

After considering the prevailing discount to net asset value at which the Company's shares currently trade and feedback provided by shareholders to Trian Investors Management, LLC (the "Investment Manager") and the Company's corporate brokers, the Board believes that using excess cash reserves to fund a share repurchase, as opposed to a dividend, would provide the greater benefit to the Company's shareholders.

As such, the Board today announces that the Company intends to use the £4 million in excess cash reserves it expects to receive from the Investment Partnership to repurchase ordinary shares of the Company (the "Share Repurchase"), as and when the Board deems it to be in the best interests of the Company, with a view to, among other things, managing imbalances between the supply and demand for Company shares. The Board retains absolute discretion as to the execution, pricing and time of the Share Repurchase, subject to the conditions set out in the authority to make market purchases conferred at the Company's 2020 Annual General Meeting, and there should be no presumption that the Share Repurchase will form part of an ongoing programme. The Company intends that any shares bought back through the Share Repurchase will be held in treasury.

 

For further information, please contact:

 

Ocorian Administration (Guernsey) Limited(Administrator and Company Secretary)+44 (0)1481 742 742Ian Smith

 

Numis Securities Limited

(Joint corporate broker) 

+44 (0)20 7260 1000

David Benda

 

Jefferies International Limited

(Joint corporate broker)

+44 (0)20 7029 8000

Stuart Klein

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCBDDIBGDGGB
Date   Source Headline
26th Apr 20234:22 pmRNSNotice of EGM Results
26th Apr 20234:21 pmRNSNotice of AGM Results
26th Apr 20237:30 amRNSSuspension - Trian Investors 1 Limited
17th Apr 20235:03 pmRNSNet Asset Value as at 31 March 2023
6th Apr 20232:55 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
24th Mar 20237:01 amRNSNotice of EGM
24th Mar 20237:00 amRNSNotice of AGM
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:00 amRNSAnnual Report to 31 December 2022
16th Mar 202312:08 pmRNSNAV as at 28 February 2023 and as at 13 March 2023
14th Mar 20232:43 pmRNSTotal Voting Rights
2nd Mar 20237:00 amRNSCompulsory Share Redemption Update
22nd Feb 20232:53 pmRNSNet Asset Value as at 16 February 2023
22nd Feb 20232:37 pmRNSNet Asset Value as at 31 January 2023
17th Feb 20237:00 amRNSCompulsory Share Redemption Update
1st Feb 20237:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSNet Asset Value as at 6 January 2023
19th Jan 20237:00 amRNSIn-specie Distribution & Complusory Redemption
9th Jan 20236:01 pmRNSNet Asset Value as at 31 December 2022
9th Jan 20237:00 amRNSCompulsory Share Redemption Update
14th Dec 20225:26 pmRNSNet Asset Value as at 30 November 2022
11th Nov 20224:34 pmRNSNet Asset Value as at 31 October 2022
26th Oct 20225:16 pmRNSReplacement - Net Asset Value(s)
25th Oct 20224:16 pmRNSNet Asset Value as at 30 September 2022
24th Oct 20228:51 amRNSHolding(s) in Company
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSNet Asset Value as at 31 August 2022
6th Sep 202210:42 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompulsory Share Redemption by 30 June 2023
15th Aug 20225:30 pmRNSChanges to Director Roles and Responsibilities
12th Aug 20227:00 amRNSNet Asset Value as at 31 July 2022
8th Aug 20227:00 amRNSResult of EGM
8th Aug 20227:00 amRNSDirector Changes
8th Aug 20227:00 amRNSResult of AGM
11th Jul 20222:01 pmRNSNotice of AGM
11th Jul 20222:00 pmRNSNotice of Requisitioned EGM
11th Jul 20227:00 amRNSNet Asset Value as at 30 June 2022
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20223:56 pmRNSReceipt of Requisition Notice
15th Jun 20227:00 amRNSNet Asset Value as at 31 May 2022
31st May 20228:00 amRNSInvestment in Unilever
6th May 20226:00 pmRNSNet Asset Value as at 30 April 2022
14th Apr 20227:01 amRNSDirector Appointment
14th Apr 20227:00 amRNSAnnual Report to 31 December 2021
13th Apr 20225:53 pmRNSNet Asset Value as at 31 March 2022
29th Mar 202210:11 amRNSNew US$100m Revolving Credit Facility
16th Mar 20224:53 pmRNSNet Asset Value as at 28 February 2022
1st Mar 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.